Attached files
EXHIBIT 32
In connection with the quarterly report of EFT BioTech Holdings, Inc., (the
"Company") on Form 10-Q for the quarter ended December 31, 2010 as filed with
the Securities and Exchange Commission (the "Report") Jack Jie Qin, the
Principal Executive and Principal Financial Officer of the Company, certifies
pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
company.
February 9, 2011 /s/ Jack Jie Qin
------------------------------
Jack Jie Qin, Principal Executive and
Financial Officer